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ABSTRACT
TFIIE and TFIIH are essential for the promoter open-
ing and escape that occurs as RNA polymerase II
transits into early elongation. XPB, a subunit of
TFIIH, contains an ATP-dependent helicase activity
that is used in both of these processes. Here, we
showthatthesmallerbetasubunitofTFIIEstimulates
the XPB helicase and ATPase activities. The larger
alpha subunit can use its known inhibitory activity
to moderate the stimulation by the beta subunit.
Regions of TFIIE beta required for the helicase stimu-
lation were identified. Mutants were constructed that
are defective in stimulating the XPB helicase but still
allow intact TFIIE to bind and recruit XPB and TFIIH
to form the pre-initiation complex. In a test for the
functional significance of the stimulatory effect of
TFIIE beta, these mutant forms of TFIIE were shown
to be defective in a transcription assay on linear
DNA. The data suggest that the beta subunit of
TFIIE is an ATPase and helicase co-factor that can
assist the XPB subunit of TFIIH during transcription
initiationandthetransitiontoearlyelongation,enhan-
cing the potential diversity of regulatory targets.
INTRODUCTION
Eukaryotic class II transcription requires at least 30 poly-
peptides for basal transcription and many more are needed
for properly regulated transcription. These polypeptides
include RNA polymerase II and components of the general
transcription factors. TFIID and TFIIB recruit the polymerase
and TFIIF to the promoter, and other factors modify the tran-
scription complex to allow it to proceed into early elongation
phase (1–3). In the step-wise model of assembly, TFIIE and
TFIIH are added immediately after polymerase (4) and are
used in the opening of the DNA and in the initial steps of RNA
synthesis, includingpromoter escape (5–10). TFIIE and TFIIH
are essential proteins in vivo (11,12). In vitro, TFIIE and
TFIIH are required for these transcription steps, although
their function can be partially bypassed on some supercoiled
templates (13).
TFIIE is composed of two subunits, a larger 56 kDa subunit
TFIIEa and a smaller 34 kDa subunit TFIIEb (14,15). The
TFIIE heterotetramer (a2b2) has no known catalytic activity
and recruits TFIIH to complete the assembly pathway
(4,8,16,17). TFIIH is a large complex with 10 subunits and
several enzymatic activities, including ATP hydrolysis,
energy-dependent DNA unwinding and phosphorylation
(18–24). Two subunits of TFIIH, XPB and XPD, can accom-
plish DNA unwinding, although the polarity of the process is
different for each (20–22). The XPD ATP-dependent helicase
is used to open DNA during repair, and its activity within
TFIIH is strong owing to the activation by its partner subunit
p44 (25,26). The XPB ATP-dependent helicase is used to open
the promoter DNA during transcription and is also used in
promoter escape (27–31). Its helicase activity within TFIIH is
weaker and its p52 partner subunit does not enhance this
activity (32). XPB and XPD have other roles that appear to
be independent of helicase action. The ATPase activity of
XPB is needed for the activation of the XPG endonuclease
during nucleotide excision repair (33). XPD provides struc-
tural integrity to TFIIH (25,26), especially to the CAK kinase
complex that is involved in the transition from transcription
initiation to elongation (16,19,24,26,28,34–36) and other
cellular processes (17,37).
Although TFIIE has no catalytic activities (14,15), it can
inﬂuence those of TFIIH (16,24,36,38). It has been reported to
positively regulate the ATPase and kinase activities of TFIIH
(19) and negatively regulate its helicase activity (39). The
negative regulation is speciﬁc to the XPB helicase (39).
From these observations, it has been suggested that TFIIE
inhibits the ability of TFIIH to open promoter DNA until
the complete complement of general transcription factors is
assembled, at which time this constraint may be relieved.
Overall, TFIIE and TFIIH likely work together to modify
the pre-initiation complex so as to allow the RNA polymerase
to function in transcription initiation and to transit to early
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doi:10.1093/nar/gki623elongation. During this critical transition process, the mRNA
becomes cappedandTFIIHbeginstocatalyze thestagedseries
of changes in the RNA polymerase CTD that sets the stage for
coupled elongation and RNA processing events. Although
TFIIE is required for this transition (19,36), its role has not
been clearly established. The role of the beta subunit is of
particular interest, as its C-terminus is crowded with interac-
tion domains for other general transcription factors (36,38).
Both the alpha and beta subunits of TFIIE can interact with
XPB (35) and it has been suggested that the alpha subunit
is dominant for the inhibition of the XPB function (39). No
speciﬁc role has emerged for the interaction of the beta subunit
with XPB, although the possibility has been raised that it func-
tions in the transition into early elongation phase (36,38).
BecausepromoteropeningandescaperequiretheXPBATPase
and helicase activities (5,28,31,40), we have investigated the
possible role of the TFIIE beta subunit in modulating these
activities. Below, we show that the isolated beta subunit can
stimulatetheXPBhelicase andATPaseactivitiesandthatsuch
stimulation has a functional role in transcription.
MATERIALS AND METHODS
Protein expression and purification
The human XPB (ERCC3) clone was a gift from the J. -M Egly
laboratory. Glutathione S-transferase (GST)-tagged XPB was
expressed and partially puriﬁed as described previously
(22,41) with the following modiﬁcations. An aliquot of
400 ml of Escherichia coli cells were induced with 0.1 mM of
isopropyl-b-D-thiogalactopyranoside (IPTG) for 30 min at
37 C. The cell pellets were collected and re-suspended in
10 ml of 1· phosphate-buffered saline (PBS) with 1% Triton 
X-100. An aliquot of 150 ml of Glutathione Sepharose 4B was
used in the batch puriﬁcation protocol as described previously
(Amersham Pharmacia Biotech). Each wash used 10 ml of 1·
PBS with 1% Triton  X-100 for a total of four washes. The
XPB was eluted with 50 mM Tris–HCl (pH 7.9), 10 mM
reduced glutathione and 50% glycerol. The eluted sample
was dialyzed against 50 mM Tris–HCl (pH 7.9) and 50%
glycerol to remove the reduced glutathione. GST was
expressed and puriﬁed the same way.
Human TFIIEa and TFIIEb clones were obtained from
Dr K. Yokomori. Human TFIIEb, its C-terminal truncated
mutants (stop codons were placed accordingly using
QuikChange  site-directed mutagenesis kit from Stratagene)
and point mutants with His6 tagged were expressed in
4–500 ml of E.coli BL21(DE3) cells in 0.3 mM IPTG, 2%
glucose and Luria–Bertani for 1 h at 37 C after OD600 nm
reached 0.5. Ni-based resin (Qiagen and Active Motive) was
used for puriﬁcation (see Qiagen’s manual for puriﬁcation
procedures and solutions). Proteins were analyzed on 12%
Tris/Glycine SDS–PAGE with the correct molecular weights
and were >95% pure. The proteins contained low but detect-
able helicase activity.
Human TFIIEa with a His6 tag was a gift from Hao Duong
(UCLA, Department of Chemistry and Biochemistry). Human
TFIIEa and N-terminal truncated mutants with an N-terminal
FLAG tag were cloned into pET11a (Novagen). They were
expressed the same way as TFIIEb (see above) and were
puriﬁed using ANTI-FLAG  M2-Agarose (Sigma, see the
manufacturer’s puriﬁcation procedures and solutions). The
proteins were eluted with FLAG peptide. They were analyzed
on 10% Tris/Glycine SDS–PAGE and were >95% pure.
Human TFIIH was purchased from Protein One (http://
www.proteinone.com).
Helicase and ATPase assays
Helicase assays were as described previously (21,22,39).
Brieﬂy, 20 ng of
32P-labeled oligonucleotide (50-AA-
ACGACGGCCAGTGAATTCGAGCTCGGTACCCGG-30)
complementary to M13mp19
+ was annealed to 1 mg of the
single-stranded plasmid DNA in 25 mM NaCl and 2.5 mM
MgCl2. The duplex substrate was then puriﬁed in a Sephadex
200 size exclusion column. An aliquot of 400–500 ng of
duplex was recovered free of un-annealed labeled oligonuc-
leotide. Helicase assays for XPB and TFIIEb or its mutants
were incubated for 30 min at 37 C in the presence of 4 mM
MgCl2, 4 mM ATP, 50 mg/ml acetylated BSA, 1 mM DTT,
20 mM Tris–HCl (pH 7.9) and 2–3 ng of DNA substrate in
25 ml of reaction volume. For TFIIH, a 30–50 XPB-speciﬁc
substrate was used. This substrate was generated from a
32P-labeled 19 nt long complementary oligonucleotide
annealed to a 49 nt long oligonucleotide, resulting in a 50
blunt end (with respect to the longer oligonucleotide) partial
duplex DNA. The reactions were stopped and run on 12%
PAGE in 1· TBE.
ATPase assays were as described previously (19,22). The
conditionsweresimilartothehelicaseassayabove, except that
1 mMo f[ g-
32P]ATP was added insteadof 4 mM ATP, reaction
volume was 12.5 ml, and the reaction times reduced to 20 min.
For the XPB and TFIIH ATPase assay, 10 ng of single-
strandedDNAand50ngofplasmidDNAwere added,respect-
ively, unless otherwise speciﬁed. The reactions were stopped
and run on PEI-TLC plates in 0.75 M potassium phosphate
(pH 4.0). All signals were detected by PhosphorImager and
analyzed by ImageQuant 5.2 software.
Co-immunoprecipitation (CoIP) and template
pull-down assays
An aliquot of 200 ml of bacterial lysate ( 2 mgtotal protein/ml)
containing expressed TFIIEa or its N-terminal truncation
mutants was incubated with 200 ml of bacterial lysate ( 2 mg
total protein/ml) containing expressed TFIIEb for 45 min at
4 C. An aliquot of 20 ml of Ni-NTA resin was added to
the mixture to bind TFIIEb for an additional 45 min. Resins
were washed twice with 400 ml of 20 mM Tris–HCl (pH 7.9)
and 100 mM NaCl and eluted with 2· SDS buffer [100 mM
Tris–HCl (pH 6.8), 200 mM DTT, 4% SDS, 0.2% bro-
mophenol blue and 20% glycerol]. The samples were resolved
by 10% Tris/Glycine SDS–PAGE and detected through
western blot using Anti-FLAG M2 peroxidase conjugate
(Sigma).
For TFIIEa and TFIIEb CoIP, 130 mg of FLAG tagged
TFIIEa non-expressed or expressed bacterial lysate were
mixed with 25 ml of anti-FLAG resin for 45 min at 4 C.
Resin was washed as above. An aliquot of 200 mlo f2 0m M
Tris–HCl (pH 7.9) and 100 mM NaCl and 1 mg of puriﬁed
TFIIEb or its mutants were added to the spun down resin and
further mixed for 45 min at 4 C. Resins were washed and
eluted with 2· SDS buffer. The samples were resolved by
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blot using Anti-TFIIEb (Santa Cruz Biotechnology). For
FLAG-tagged TFIIEb and His6 tagged TFIIEb CoIP, Anti-
His peroxidase conjugate (Qiagen) was used in western blot
detection.
For XPB and TFIIEb CoIP, 8 mg of GST or XPB were
pre-incubated with 2 mg of TFIIEb or its mutants on ice for
45 min. Subsequently, 50 ml of glutathione resin (Amersham)
and 400 ml of 20 mM Tris–HCl (pH 7.9) and 100 mM NaCl
were mixed with the pre-incubated proteins for 45 min at 4 C.
IIEβ [µl]
Figure 1. TFIIEb stimulatesXPB helicase activity. (A) Helicase assay. Lane 1, substrate alone; lane 2, substrate heated for 2 min to unanneal radioactively labeled
oligonucleotide;lane3,0.8mgTFIIEbwasadded;lane4,2.4mgofXPBwasadded;lanes5and6,0.4and0.8mgofTFIIEwereaddedto2.4mgofXPB,respectively.
(B)Agraphicalrepresentationoflane4–6in(A).(C)Helicaseassay.Lane1,substratealone;lane2,0.8mgofTFIIEband2.4mgofGSTwereadded;lane3,0.8mgof
TFIIEb and 11 mg of GST were added;lane 4, 0.8 mg of TFIIEb were added to 2.4 mg of XPB. (D) ATPase assay. Lane 1, ATP alone; lane 2, 0.13 mg of TFIIEb was
added; lane 3, 0.8 mg of XPB was added; lane 4 contained both 0.13 mg of TFIIEb and 0.8 mg of XPB. The ATPase stimulation was 1.8 – 0.4-fold.
3074 Nucleic Acids Research, 2005, Vol. 33, No. 9Resins were washed and eluted with 2· SDS buffer. The
samples were resolved by 10% Tris/Glycine SDS–PAGE
and detected through western blot using Anti-TFIIEb (Santa
Cruz Biotechnology).
The pre-initiation complex pull-down assay was performed
similarly as described previously (42). Brieﬂy, the 100 ml
reaction contained 400 mg of TFIIEb depleted extract,
7.5 mM MgCl2, 0.05% NP-40, 1 mg/ml of acetylated bovine
albumin, 1 mg of pGEM, 20 ng of TFIIEb or its mutants, 15 ng
of TFIIEa, 250 U Gal4-AH (ProteinOne) and the magnetic
beads (Dynal) with the biotinylated G9E4 or promoter-less
DNA (320 nt long). An aliquot of 0.2 pmol of E4 fragment
was also added to each reaction. Incubations were at room
temperature for 30 min. The beads were washed twice with
100 ml of Buffer D with 0.5% of NP-40.
In vitro transcription
HeLa nuclear extract (43) was immunodepleted with TFIIE
using Protein A-agarose pre-bound with anti-IIE beta antibody
(IIEb C-21 from Santa Cruz Biotechnology). The immuno-
precipitation protocol was as described previously (44).
In vitro transcription was performed as described previously
(43). Brieﬂy, the 25 ml reaction contained  70 mg of immun-
odepleted extract, 4 mM MgCl2,  200 ng of linearized AdML
fragment with 5 Gal sites and a G-less cassette or 400 ng of
linearized E4 fragment with 9 Gal sites, 200 ng of Gal4-VP16
(Protein One), 0.4 mM of ATP, 0.4 mM of CTP and 0.016 mM
of [a-
32P]UTP (Perkin-Elmer) (and 0.4 mM of GTP was
included for E4 transcription). An aliquot of 90 ng of IIEa
and 60 ng of wild-type IIEb or its mutants were allowed to
Figure 2. TheC-terminusofTFIIEb isimportantforthestimulationofXPBhelicaseactivity.(A)AdiagramofTFIIEbfunctionaldomains(36)andtheC-terminal
truncationmutantsofIIEbweredepicted.(B)Helicaseassay,conditionsasinFigure1A.Lane1,substratealone;lane2,substrateheatedfor2min;lane3,XPBwas
added;lane4,asinlane3,exceptwild-typeTFIIEbwasadded;lane5,equimolarofD257–291asinlane4TFIIEbwasaddedtoXPB;lane6,D197–291wasaddedto
XPB; lane 7, D149–291 was added to XPB. (C) A graphical representation of XPB helicase stimulation by wild-type and various TFIIEb mutants.
Nucleic Acids Research, 2005, Vol. 33, No. 9 3075incubate for 10 min before the addition of other components in
the reaction. The reaction was stopped after 60 min at 30 C,
phenol–chloroform extracted and ethanol precipitated.
Formamide dye was added to the pellet, loaded on to a 6%
urea polyacrylamide gel and run for 80 min at 32 W. The
signals were detected by PhosphorImager and analyzed by
ImageQuant 5.2 software.
RESULTS
TFIIEb stimulates XPB helicase and ATPase activities
We ﬁrst tested the effect of the isolated TFIIEb subunit on the
enzymatic activities of the isolated XPB subunit of TFIIH.The
results of helicase assays using puriﬁed human XPB and
TFIIEb are shown in the autoradiogram of Figure 1. Electro-
phoresis was used to follow the release of a radioactively
labeled oligonucleotide (of length 35 nt) from a partial DNA
duplex. The partial duplex is shown in lane 1, and the labeled
oligonucleotide,releasedartiﬁciallybyheat,isshowninlane2.
The lack of release in lane 3 conﬁrms that TFIIEb has low
intrinsic helicase activity. When XPB is assayed (lane 4), the
knownweakhelicaseactivityisrepresentedbythelowamount
of released substrate. When TFIIEb is added to XPB, there is
more released substrate (lanes 5 and 6) showing that TFIIEb
has stimulated the XPB helicase activity. The stoichiometries
of TFIIEb and XPB are 1:2 in lane 5 and 1:1 in lane 6. In
Figure 1C, the stimulation of XPB helicase by TFIIEb is
conﬁrmed and shown to be unrelated to the GST tag attached
to the recombinant protein.
A titration was used to follow the quantitative stimulation
(Figure 1B), which increases with increasing amounts of
TFIIEb. When the amount is raised further, the helicase activ-
ity falls (data not shown). This may be related to the preval-
ence of beta dimers at the higher concentration, as TFIIEb
exists in monomeric and dimeric states (11). At the optimal
TFIIEb concentration the stimulation of XPB helicase activity
is 4- to 5-fold under these conditions.
The effect of the isolated beta subunit on the XPB ATPase
activityinthepresenceofDNAwasalsotested.Thisactivityis
needed for helicase action but also may act independently in
some circumstances (33,45). The ATPase is assayed by
observing the release of radioactive phosphate from
gamma-labeled ATP, and Figure 1D shows that XPB
(lane 3) but not TFIIEb (lane 2) has ATPase activity, as expec-
ted. When TFIIEb is added to XPB, its ATPase activity
increases  2-fold (lane 4). We conclude that TFIIEb can
stimulate the helicase and ATPase activities of the isolated
XPB subunit of TFIIH.
Domain determinants of helicase stimulation
We used a series of C-terminal deletion mutants (Figure 2A) to
learn the region(s) of TFIIEb that is important for the XPB
helicase stimulation. C-terminal deletions were used because
the small C-terminal basic region–helix–loop sequence is
crowded with potential functions and is needed for transcrip-
tion(36,38).When thissmall35aminoacidregionisremoved,
there is much less stimulation (Figure 2B, lane 5 versus
lane 4). The residual helicase stimulation is removed upon
further deletion, which also includes the leucine-rich sigma
3 region (lane 7 versus lane 3; summarized in Figure 2C). It
appears that a large region of the C-terminus is involved in
stimulation.
XPB is in a different context when incorporated into the
multi-subunit TFIIH, which contains nine other polypeptides,
including its binding partner p52 and another helicase, XPD.
We wished to learn whether TFIIEb would still stimulate XPB
helicase activity in this context. To avoid a signal from
the XPD helicase activity, an XPB-speciﬁc 30–50 helicase
substrate was used (21,22).
Figure 3A shows that the isolated beta subunits retain the
ability to stimulate the XPB helicase in the context of intact
TFIIH (compare lane 8 with lane 7 and compare lane 6 with
lane 5), although the stimulation is less using this assay
( 2-fold). Figure 3B shows that TFIIEb also stimulates
the ATPase activity of TFIIH (lane 4 versus lane 3), as
would be expected based on the property of isolated XPB
(see above). We conclude that TFIIEb stimulates the enzym-
atic activities of XPB, both in isolated form and in the context
of TFIIH.
Figure 3. TFIIEbstimulatesTFIIHhelicaseandATPaseactivity.(A)Helicase
assay. Lane 1, XPB 30–50 helicase specific substrate; lane 2, substrate was
heated for 1 min; lane 3, 5 and 7 contained 30 ng of TFIIH and the reaction
times were 15, 30 and 45 min, respectively; lane 4, 6 and 8 contained 80 ng of
TFIIEb and 30 ng of TFIIH and the reaction times are 15, 30 and 45 min,
respectively.(B)ATPaseassay.Lane1,ATPalone;lane2,80ngofTFIIEbwas
added;lane3,60ngofTFIIHwasadded;lane4contained80ngofTFIIEband
60 ng of TFIIH. The ATPase stimulation was 2.2 – 0.4-fold.
3076 Nucleic Acids Research, 2005, Vol. 33, No. 9TFIIEa counteracts TFIIEb stimulation of the XPB
helicase
In contrast to the above results, the TFIIE complex, consist-
ing of an a2b2 tetramer, is known to have the capacity to
negatively regulate the helicase activity of XPB and TFIIH
(14,39). This negative regulation is lessened in the presence
of an antibody to the alpha subunit (39). These observations
raise the possibility that the beta subunit has stimulation
potential but in the context of intact TFIIE it can be mod-
erated by the inhibitory potential of the alpha subunit. To
test directly whether alpha can inhibit the stimulatory effect
of beta, TFIIEa was allowed to form a complex with
TFIIEb before the addition of XPB and its helicase sub-
strate. As alpha is titrated against beta, the stimulatory
activity of beta falls progressively (Figure 4A, lanes 3–5
and summarized in Figure 4B), conﬁrming the moderation
effect of the alpha subunit of the helicase stimulation by the
beta subunit.
TFIIEa inhibits the XPB helicase directly, rather than
working through TFIIEb
We tested the possibility that TFIIEa moderates the TFIIEb
helicase stimulation through its interaction with TFIIEb. Two
N-terminal deletion mutants of TFIIEa were constructed
(Figure 5A) that would be expected to prevent the formation
of a complex with TFIIEb (16). The CoIP experiment in
Figure 5B conﬁrms that the wild-type TFIIEa binds TFIIEb
(lane 2) but that N-terminal truncations of amino acids 1–49
(lane3)or1–66(lane4)preventtheassociationofTFIIEawith
TFIIEb.
The non-interacting mutant 50–439 was then tested for the
ability to inhibit TFIIEb-stimulated XPB helicase activity.
Figure 5C shows that the inhibition is still intact, even though
the mutant TFIIEa can no longer bind TFIIEb. The inhibition
by the non-interacting alpha mutant is comparable with that of
wild-type TFIIEa (compare lanes 5 and 6 with the stimulated
control in lane 4). We conclude that the ability of TFIIEa
to inhibit stimulation of XPB helicase activity does not depend
on its association with TFIIEb. Apparently, TFIIEb and
TFIIEa can act independently directly on XPB, one to
stimulate and the other to inhibit.
TFIIEb mutants defective in the stimulation of the XPB
helicase are also defective in transcription
To examine the physiological relevance of the IIE beta stimu-
lation of the XPB helicase, we attempted to identify and test
Figure 5. TFIIEabindstoXPBtocounteractTFIIEbstimulation.(A)Western
blot of wild-type TFIIEa and its mutants. (B) CoIP of TFIIEb with wild-type
TFIIEa and its mutants. (C) Helicase assay. Lane 3, XPB was added; lane 4,
TFIIEbandXPBwereadded(70%ofsubstratewasunwound);lanes5and6as
in lane 4, except 2.4 mg of TFIIEa or 50–439 were added, respectively ( 30%
of substrate were unwound for both).
Figure 4. TFIIEa prevents TFIIEb from stimulating XPB. (A) Helicase assay.
Lane 1, substrate alone; lane 2, XPB was added; lane 3, 0.8 mg of TFIIEb and
XPBwereincluded.Forlanes4and5,1.6and3.2mg,respectively,ofIIEawere
incubated with0.8 mg of TFIIEb for15 min beforethe addition of XPBand the
substrate.(B)Agraphicalrepresentationofthehelicaseactivitiesofsamplesin
lanes 3–5.
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defective in helicase stimulation. The data of Figure 2 showed
that the deletion of the C-terminal BR-HL region lessens hel-
icase stimulation and further deletion through the LR sigma 3
region reduces the residual activity, implicating multiple
regions. The C-terminal BR-HLH is dense with overlapping
functions (38). These include the IIE–alpha interaction (36,38)
that is presumed to be important for recruitment. Therefore,
mutants in this region would be expected to alter multiple
interactions, not just stimulation of the XPB helicase. In con-
trast, no functions have yet been ascribed to the LR sigma
3 region, although it is known that its deletion results in a loss
of basal transcription activity on a linearized template (36).
Several mutants were made in this region. These changed
highly conserved hydrophobic residues to the hydrophilic
serine (I171S and I189S). The extract was immunodepleted
so as to make transcription depend on added wild-type TFIIE
(44); this was reproduced with wild-type TFIIE (Figure 6A,
depleted lane 1 versus lane 2 with TFIIE added back). In
contrast, transcription was strongly (Figure 6A, lane 3 versus
lane 2) or partially (lane 4 versus lane 2) defective when
the mutant forms of TFIIE were added back. These two
mutants were also found to be associated with defects in
stimulated XPB helicase activity (Figure 6B, lanes 3 and
4 versus the wild-type in lane 2). Defects in XPB helicase
activity are known to be led to defects in transcription
(5,28), so the transcription defect associated with these
TFIIE mutants is most likely due to lower XPB helicase activ-
ity (Figure 6A and B), although other contributions cannot
be excluded.
Figure6.MutantsthatfailtostimulateXPBhelicaseactivityalsohavetranscriptiondefects.(A)InvitrotranscriptionattheAdMLpromoter.Lane1,TFIIEdepleted
extract; lane 2, complementation of wild-type TFIIEb and TFIIEa; lane 3, with mutant I171S and TFIIEa ( 0% transcription activity compared with wild-type);
lane 4, with mutant I189S and TFIIEa ( 60% transcription activity compared with wild-type). (B) Helicase assay. Lane 1, 2 mg of XPB; lane 2, XPB and 1.2 mgo f
wild-typeTFIIEb(3-foldstimulation);lane3,XPBand1.2mgofI171S;lane4,XPBand1.2mgofI189S.Onlythereleasedoligoisshown.(C)CoIPwithTFIIEband
generaltranscriptionfactors.Toppanel:lane1,anti-FLAGresinpluswild-typeTFIIEb;lanes2–4anti-FLAGresinpre-boundwithFLAG-taggedTFIIEapluswild-
typeTFIIEoritsmutants.Middlepanel:lane1,glutathioneresinwithGSTpluswild-typeTFIIEb;lanes2–4glutathioneresinwithGST–XPBpluswild-typeTFIIEb
or its mutants. Bottom panel: lane 1, anti-FLAG resin plus wild-type TFIIEb with His6 tag; lanes 2–4, anti-FLAG resin pre-bound with FLAG-tagged wild type
TFIIEb6·Histagoritsmutants.(D)Pre-initiationcomplexformationofwild-typeTFIIEbanditsmutants.Lane1,beadswithequimolarofthetemplatewithoutthe
E4promoterandgalsitesareincubatedwithTFIIEbdepletedextractcomplementwithrecombinantwild-typeTFIIE.Lanes2–4,beadsboundtoG9E4templateare
incubated with recombinant wild-type TFIIE, I171S or I189S, respectively. The left panel indicates the transcription factors that are being probed.( E) In vitro
transcriptionattheG9E4promoter.Lane1,TFIIEdepletedextract;lane2,complementationofwild-typeTFIIE;lane3,withmutantI171SandTFIIEa;lane4,with
mutant I189S and TFIIEa.
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using a CoIP assay (8). First, the two beta mutants bind
TFIIEa comparably with wild-type (Figure 6C, top row, com-
pare mutants in lanes 3 and 4 with the wild-type in lane 2).
Second, the beta subunits are known to dimerize as part of
intact TFIIE (11) and this beta dimerization function is normal
(Figure 6C, bottom panel). Third, the binding of beta to XPB is
also comparable for the mutants and wild-type (Figure 6C,
middle panel).
Although this region would not be expected to affect
pre-initiation complex formation, as the C-terminus binds
the alpha subunit presumably required for assembly, this
was tested directly using an immobilized template pull-
down assay with a biotinylated promoter (42). A G9E4 tem-
plate was chosen over the AdML G-less cassette template used
earlier because the G-less cassette appeared to bind a signi-
ﬁcant amount of factors non-speciﬁcally (data not shown). The
wild-type transcription complex was shown to be functional as
hydrolysable NTPs resulted in polymerase II and TFIIH leav-
ing the complex (data not shown) (42).
Figure 6D shows that transcription factors were recruited to
thetemplate,whetherthewild-typeorthemutantformsofbeta
werepresent.TheseincludetheRNApolymeraseitself(second
to bottom row) and two subunits of TFIIH, XPB (top row) and
p62 (bottom row); the control in this case was the use of
promoter-less DNA (compare this control in column 1 with
promoter DNA pull-downs in columns 2–4). Although the
wild-type and mutant TFIIE subunits were also pulled down
comparably, we could not conﬁrm the promoter speciﬁcity of
the interactions (again compare with column 1 in this context).
Overall, the data demonstrate that the TFIIEb mutants
recruit TFIIH to the template but are defective in stimulating
the TFIIH XPB helicase activity. The associated transcription
defect is re-conﬁrmed using the same E4 template used in the
template pull-down assay (lanes 3 and 4 versus lane 2 of
Figure 6E), which complements the transcription data for
the ML template (Figure 6A).
DISCUSSION
The ATP-dependent XPB helicase activity of TFIIH is used
in triggering promoter-bound RNA polymerase II to progress
through initiation and into early elongation (27,28,30,31,34).
The enzyme activity in vitro is known to be very low; con-
tributions may include the lack of a binding partner, such as
p44, which stimulates the TFIIH XPD helicase (25,26) and
inhibition by the alpha subunit of TFIIE (39). In this paper, we
show that the ATPase and helicase activities of XPB can be
strengthened by its partnering with the beta subunit of TFIIE.
This stimulation appears to be functionally signiﬁcant as point
mutations in TFIIEb that have defects in XPB stimulation are
alsodefective intranscription;incontrast,themutationsdonot
interfere with the recruitment of XPB to the transcription
complex or with TFIIEb binding to TFIIEa.
The stimulatory activity of the TFIIEb subunit can be
counter-acted by the inhibitory activity of its alpha partner
subunit. The current data show that the stimulatory activity
of TFIIEb and the inhibitory activity of TFIIEa act independ-
ently, i.e. each works directly on XPB. This suggests that the
TFIIE complexmaybebuiltsothatithasthepotentialtoeither
activate or inhibit. Photo-cross-linking data (46) suggest that
ATP causes TFIIEa to re-arrange so as to better engage the
downstream region of the transcription bubble (from +4t o+8)
during promoter opening, while no accompanying change in
the positioning of the beta subunit was detected. It is possible
that this re-arrangement within TFIIE releases the beta subunit
to stimulate the ATP-dependent XPB helicase to enhance the
subsequent promoter escape steps. The data show that it is the
C-terminus of TFIIEb that accomplishes this. Because this
region interacts with many components of the transcription
complex (36,38), the data raise the possibility that it has a role
in multiple re-modeling interactions subsequent to complex
assembly (47–49).
Among RNA polymerases, only RNA polymerase II
requires a helicase to transit to elongation mode following
recruitment to the promoter (50–52), and TFIIH and TFIIE
have evolved to meet this unique requirement. This mechan-
ism enhances the potential diversity of regulation and factors
may exist that target the TFIIEb helicase stimulatory activity
to control the entry of the promoter-bound RNA polymerase
into elongation phase. This transition involves the opening of
DNA around the start site (7,52) and the release of factors
holding RNA polymerase to the promoter (48,49), leading to
the addition of factors that couple transcription elongation and
RNA processing (47). These steps cannot occur without the
action of the ATP-dependent XPB helicase (13,30,31,36,38),
which the current data suggest that it is controlled by TFIIEb.
Such considerations raise the possibility that any or all steps
could be potential targets for regulation via the TFIIEb-
stimulated ATP-dependent helicase activity, although the
recent demonstration that helicase action comes into play dir-
ectly after promoter opening (Y. C. Lin and J. D. Gralla,
accepted by Nature Structural and Molecular Biology) favors
a primary role in providing the energy needed to re-model
open pre-initiation complexes and drive RNA polymerase
into elongation mode.
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